Opioid Induced Constipation (OIC) Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

Table of Content

1 Industrial Chain Overview

• 1.1 Opioid Induced Constipation (OIC) Drugs Industry
  • 1.1.1 Overview
  • 1.1.2 Characteristics of Opioid Induced Constipation (OIC) Drugs
• 1.2 Upstream
  • 1.2.1 Major Materials
  • 1.2.2 Manufacturing Overview
• 1.3 Product List By Drug Type
  • 1.3.1 Lubiprostone
  • 1.3.2 Methyl Naltrexone Bromide
  • 1.3.3 Naldemedine
  • 1.3.4 Alvimopan
  • 1.3.5 Others
• 1.4 Product List By Prescription Type
  • 1.4.1 Generic and Branded Prescribed Drugs
  • 1.4.2 Over The Counter Drugs
• 1.5 End-Use List
  • 1.5.1 Demand in Hospital Pharmacies
  • 1.5.2 Demand in Retail Pharmacies
  • 1.5.3 Demand in Online Pharmacies
• 1.6 Global Market Overview
  • 1.6.1 Global Market Size and Forecast, 2015-2025
  • 1.6.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
  • 1.6.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
  • 1.6.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

• 2.1 Global Production & Consumption
  • 2.1.1 Global Production
  • 2.1.2 Global Consumption
• 2.2 Geographic Production & Consumption
  • 2.2.1 Production
    • 2.2.1.1 Asia-Pacific
    • 2.2.1.2 North America
    • 2.2.1.3 South America
    • 2.2.1.4 Europe
    • 2.2.1.5 Middle East & Africa
  • 2.2.2 Consumption
    • 2.2.2.1 Asia-Pacific
    • 2.2.2.2 North America
    • 2.2.2.3 South America
    • 2.2.2.4 Europe
    • 2.2.2.5 Middle East & Africa

  3 Major Manufacturers Introduction

  • 3.1 Manufacturers Overview
  • 3.2 Manufacturers List
    • 3.2.1 Ironwood Pharmaceuticals Inc Overview
      • 3.2.1.1 Product Specifications
      • 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.1.3 Recent Developments
      • 3.2.1.4 Future Strategic Planning
    • 3.2.2 Daiichi Sankyo Co Ltd Overview
      • 3.2.2.1 Product Specifications
      • 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.2.3 Recent Developments
      • 3.2.2.4 Future Strategic Planning
    • 3.2.3 Pfizer Overview
      • 3.2.3.1 Product Specifications
      • 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.3.3 Recent Developments
      • 3.2.3.4 Future Strategic Planning
    • 3.2.4 Progenics Pharmaceuticals Inc Overview
      • 3.2.4.1 Product Specifications
      • 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.4.3 Recent Developments
      • 3.2.4.4 Future Strategic Planning
    • 3.2.5 Shionogi & Co., Ltd Overview
      • 3.2.5.1 Product Specifications
      • 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.5.3 Recent Developments
      • 3.2.5.4 Future Strategic Planning
    • 3.2.6 Allergan Plc Overview
      • 3.2.6.1 Product Specifications
      • 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.6.3 Recent Developments
      • 3.2.6.4 Future Strategic Planning
    • 3.2.7 Nektar Therapeutics Overview
      • 3.2.7.1 Product Specifications
      • 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.7.3 Recent Developments
      • 3.2.7.4 Future Strategic Planning
    • 3.2.8 Purdue Pharma Overview
      • 3.2.8.1 Product Specifications
      • 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.8.3 Recent Developments
      • 3.2.8.4 Future Strategic Planning
    • 3.2.9 S.L.A. Pharma AG Overview
      • 3.2.9.1 Product Specifications
      • 3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.9.3 Recent Developments
      • 3.2.9.4 Future Strategic Planning
    • 3.2.10 Mundipharma International Limited Overview
      • 3.2.10.1 Product Specifications
      • 3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.10.3 Recent Developments
      • 3.2.10.4 Future Strategic Planning
    • 3.2.11 Ono Pharmaceutical Co., Ltd Overview
      • 3.2.11.1 Product Specifications
      • 3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.11.3 Recent Developments
      • 3.2.11.4 Future Strategic Planning
    • 3.2.12 Takeda Pharmaceutical Company Limited Overview
      • 3.2.12.1 Product Specifications
      • 3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.12.3 Recent Developments
      • 3.2.12.4 Future Strategic Planning
    • 3.2.13 Theravance Biopharma Inc Overview
      • 3.2.13.1 Product Specifications
      • 3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.13.3 Recent Developments
      • 3.2.13.4 Future Strategic Planning
    • 3.2.14 Valeant Pharmaceuticals International Overview
      • 3.2.14.1 Product Specifications
      • 3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.14.3 Recent Developments
      • 3.2.14.4 Future Strategic Planning
    • 3.2.15 Cosmo Pharmaceuticals SA Overview
      • 3.2.15.1 Product Specifications
      • 3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.15.3 Recent Developments
      • 3.2.15.4 Future Strategic Planning
    • 3.2.16 Daewoong Pharmaceutical Overview
      • 3.2.16.1 Product Specifications
      • 3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.16.3 Recent Developments
      • 3.2.16.4 Future Strategic Planning
    • 3.2.17 C.B. Fleet Company Overview
      • 3.2.17.1 Product Specifications
      • 3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.17.3 Recent Developments
      • 3.2.17.4 Future Strategic Planning
    • 3.2.18 Sucampo Pharmaceuticals Overview
      • 3.2.18.1 Product Specifications
      • 3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.18.3 Recent Developments
      • 3.2.18.4 Future Strategic Planning

    4 Market Competition Pattern

    • 4.1 Market Size and Sketch
    • 4.2 Company Market Share
      • 4.2.1 Global Production by Major Manufacturers
      • 4.2.2 Market Concentration Analysis
    • 4.3 Market News and Trend
      • 4.3.1 Merger & Acquisition
      • 4.3.2 New Product Launch

    5 Product Type Segment

    • 5.1 Global Overview by Product Type Segment
    • 5.2 Segment Subdivision by Drug Type
      • 5.2.1 Market in Lubiprostone
        • 5.2.1.1 Market Size
        • 5.2.1.2 Situation & Development
      • 5.2.2 Market in Methyl Naltrexone Bromide
        • 5.2.2.1 Market Size
        • 5.2.2.2 Situation & Development
      • 5.2.3 Market in Naldemedine
        • 5.2.3.1 Market Size
        • 5.2.3.2 Situation & Development
      • 5.2.4 Market in Alvimopan
        • 5.2.4.1 Market Size
        • 5.2.4.2 Situation & Development
      • 5.2.5 Market in Others
        • 5.2.5.1 Market Size
        • 5.2.5.2 Situation & Development
    • 5.3 Segment Subdivision by Prescription Type
      • 5.3.1 Market in Generic and Branded Prescribed Drugs
        • 5.3.1.1 Market Size
        • 5.3.1.2 Situation & Development
      • 5.3.2 Market in Over The Counter Drugs
        • 5.3.2.1 Market Size
        • 5.3.2.2 Situation & Development

      6 End-Use Segment

      • 6.1 Global Overview by End-Use Segment
      • 6.2 Segment Subdivision
        • 6.2.1 Market in Hospital Pharmacies
          • 6.2.1.1 Market Size
          • 6.2.1.2 Situation & Development
        • 6.2.2 Market in Retail Pharmacies
          • 6.2.2.1 Market Size
          • 6.2.2.2 Situation & Development
        • 6.2.3 Market in Online Pharmacies
          • 6.2.3.1 Market Size
          • 6.2.3.2 Situation & Development

        7 Market Forecast & Trend

        • 7.1 Regional Forecast
        • 7.2 Consumption Forecast
          • 7.2.1 Product Type Forecast by Drug Type
          • 7.2.2 Product Type Forecast by Prescription Type
          • 7.2.3 End-Use Forecast
        • 7.3 Investment Trend
        • 7.4 Consumption Trend

        8 Price & Channel

        • 8.1 Price and Cost
          • 8.1.1 Price
          • 8.1.2 Cost
        • 8.2 Channel Segment

        9 Market Drivers & Investment Environment

        • 9.1 Market Drivers
        • 9.2 Investment Environment

        10 Research Conclusion

        List of Tables

        Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by Drug Type with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by Prescription Type with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

        Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

        Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

        Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Major Manufacturers Headquarters and Contact Information

        Table Major Manufacturers Capacity List in 2018

        Table Ironwood Pharmaceuticals Inc Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Ironwood Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Daiichi Sankyo Co Ltd Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Daiichi Sankyo Co Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Pfizer Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Progenics Pharmaceuticals Inc Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Progenics Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Shionogi & Co., Ltd Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Shionogi & Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Allergan Plc Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Allergan Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Nektar Therapeutics Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Nektar Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Purdue Pharma Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Purdue Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table S.L.A. Pharma AG Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of S.L.A. Pharma AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Mundipharma International Limited Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Mundipharma International Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Ono Pharmaceutical Co., Ltd Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Ono Pharmaceutical Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Takeda Pharmaceutical Company Limited Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Takeda Pharmaceutical Company Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Theravance Biopharma Inc Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Theravance Biopharma Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Valeant Pharmaceuticals International Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Valeant Pharmaceuticals International (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Cosmo Pharmaceuticals SA Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Cosmo Pharmaceuticals SA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Daewoong Pharmaceutical Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Daewoong Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table C.B. Fleet Company Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of C.B. Fleet Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Sucampo Pharmaceuticals Overview List

        Table Opioid Induced Constipation (OIC) Drugs Business Operation of Sucampo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

        Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

        Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

        Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

        Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

        Table Global Market Forecast by Region Segment 2019-2025, in Million USD

        Table Global Market Forecast by Region Segment 2019-2025, in Volume

        Table Global Market Amount by Drug Type Segment 2019-2025, in Million USD

        Table Global Market Volume by Drug Type Segment 2019-2025, in Volume

        Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

        Table Global Market Volume by End-Use Segment 2019-2025, in Volume

        List of Figures

        Figure Opioid Induced Constipation (OIC) Drugs Picture List

        Figure Global Market Size and Forecast with Growth Rate, 2015-2025

        Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

        Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Global Production Volume Share by Manufacturers in 2019, in Volume

        Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

        Figure Global Market Amount and Growth Rate in Lubiprostone, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Lubiprostone, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Naldemedine, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Naldemedine, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Alvimopan, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Alvimopan, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Generic and Branded Prescribed Drugs, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Generic and Branded Prescribed Drugs, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Over The Counter Drugs, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Over The Counter Drugs, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Retail Pharmacies, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Retail Pharmacies, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Online Pharmacies, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Online Pharmacies, 2015-2018, in Volume